Clinical Trial Update: Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of Sapanisertib and Serabelisib with Paclitaxel, plus a substudy of an insulin-suppressing diet, in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Sapanisertib (sapanisertib)
• Serabelisib (serabelisib)

Snippet

Sponsor: Faeth Therapeutics | Conditions: Endometrial Cancer | Phase 2 | Status: RECRUITING